Company intelligence / Profile preview

Visior Technologies

Ownership: Private
Development stage: Preclinical

Overview

Visior Technologies is a clinical-stage medical device company developing commercial, video-based, noninvasive solutions for the delivery of visual and auditory stimulation. Their technology targets both eye and brain diseases. No published clinical results are available in public sources as of now.

Therapeutic areas: OphthalmologyNeurology
Modalities: DeviceNon-pharmacological therapy (video-based visual and auditory stimulation)
Industry: Digital Health Medical Devices

Drug pipeline

1 asset

reviView

Pre-clinical

Indications: Amblyopia, Glaucoma

Beyond the preview

Go deeper on Visior Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Visior Technologies.

Explore the full profile